A Trusted Local Solution for Non-invasive Prenatal Testing
Non-invasive prenatal testing (NIPT) has been proven superior to traditional screening methods for detecting common fetal aneuploidies. By reducing false positive rates, NIPT helps limit invasive procedures—and therefore, the risk of miscarriage—when used as a primary screen.
BGI has many years experience providing the NIFTY® Test to partners across the world, and has processed more than 3 million samples to date. As a trusted NIPT provider, we are proud to offer the next step in the evolution of NIPT testing by offering a local laboratory solution powered by our own proprietary sequencing platform, the BGISEQ-500.